2,102 results on '"Walter C. Willett"'
Search Results
2. Racial and ethnic heterogeneity in diets of low-income adult females in the United States: results from National Health and Nutrition Examination Surveys from 2011 to 2018
- Author
-
Briana Joy K. Stephenson and Walter C. Willett
- Subjects
Nutrition and Dietetics ,Medicine (miscellaneous) - Published
- 2023
3. Promoting Reproducibility and Integrity in Observational Research: One Approach of an Epidemiology Research Community
- Author
-
Konrad H. Stopsack, Lorelei A. Mucci, Shelley S. Tworoger, Jae H. Kang, A. Heather Eliassen, Walter C. Willett, and Meir J. Stampfer
- Subjects
Epidemiology - Published
- 2023
4. Sugar-sweetened beverage consumption and weight gain in children and adults: a systematic review and meta-analysis of prospective cohort studies and randomized controlled trials
- Author
-
Michelle Nguyen, Sarah E. Jarvis, Maria G. Tinajero, Jiayue Yu, Laura Chiavaroli, Sonia Blanco Mejia, Tauseef A. Khan, Deirdre K. Tobias, Walter C. Willett, Frank B. Hu, Anthony J. Hanley, Catherine S. Birken, John L. Sievenpiper, and Vasanti S. Malik
- Subjects
Nutrition and Dietetics ,Medicine (miscellaneous) - Published
- 2023
5. Insulinemic potential of diet and risk of total and subtypes of breast cancer among US females
- Author
-
Andrea Romanos-Nanclares, Fred K Tabung, Walter C Willett, Bernard Rosner, Michelle D Holmes, Wendy Y Chen, Rulla M Tamimi, and A Heather Eliassen
- Subjects
Nutrition and Dietetics ,Adolescent ,Risk Factors ,Hyperinsulinism ,Humans ,Medicine (miscellaneous) ,Female ,Breast Neoplasms ,Insulin Resistance ,Energy Intake ,Diet - Abstract
Insulin resistance and hyperinsulinemia play important roles in the progression of multiple chronic disease and conditions. Diet modulates insulin response; however, evidence is limited regarding whether diets with higher insulinemic potential increase the risk of invasive breast cancer.We aimed to prospectively evaluate the association between a food-based empirical dietary index for hyperinsulinemia (EDIH) and the incidence of invasive breast cancer.We prospectively followed 76,686 women from the Nurses' Health Study (NHS; 1984-2016) and 93,287 women from the Nurses' Health Study II (NHSII; 1991-2017). Diet was assessed by food-frequency questionnaires every 4 y. The insulinemic potential of diet was evaluated using the previously established EDIH based on circulating C-peptide concentrations. Higher scores indicate higher insulinemic potential of the diet. Covariates included reproductive, hormonal, and anthropometric factors (height and BMI at age 18 y); race; socioeconomic status; total alcohol intake; total caloric intake; and physical activity.During 4,216,106 person-years of follow-up, we documented 10,602 breast cancer cases (6689 NHS, 3913 NHSII). In the pooled multivariable-adjusted analyses, women in the highest, compared with the lowest, EDIH quintile (Q) were at higher breast cancer risk (HRQ5 vs. Q1 = 1.15; 95% CI: 1.07, 1.24; P-trend 0.01). Although heterogeneity by estrogen receptor (ER) status was nonsignificant, the strongest association between EDIH and breast cancer was observed for ER-negative tumors (HRQ5 vs. Q1 = 1.21; 95% CI: 1.00, 1.46; P-trend = 0.02). Among tumor molecular subtypes, the strongest associations were observed for human epidermal growth factor receptor 2 (HER2)-enriched tumors (HRQ5 vs. Q1 = 1.62; 95% CI: 1.01, 2.61; P-trend = 0.02).A dietary pattern contributing to hyperinsulinemia and insulin resistance was associated with greater breast cancer risk, especially ER-negative and HER2-enriched tumors. Our findings suggest that dietary modifications to reduce insulinemic potential may reduce the risk of breast cancer.
- Published
- 2022
6. Long-term diet and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) severity
- Author
-
Yiyang Yue, Wenjie Ma, Emma K Accorsi, Ming Ding, Frank Hu, Walter C Willett, Andrew T Chan, Qi Sun, Janet Rich-Edwards, Stephanie A Smith-Warner, and Shilpa N Bhupathiraju
- Subjects
Nutrition and Dietetics ,SARS-CoV-2 ,Hyperinsulinism ,Humans ,COVID-19 ,Medicine (miscellaneous) ,Diet, Mediterranean ,Pandemics ,Follow-Up Studies - Abstract
The role of diet on Coronavirus Disease 2019 (COVID-19) is emerging. We investigated the association between usual diet before the onset of the pandemic and risk and severity of subsequent SARS-CoV-2 infection.We included 42,935 participants aged 55-99 y in 2 ongoing cohort studies, the Nurses' Health Study II and Health Professionals Follow-up Study, who completed a series of COVID-19 surveys in 2020 and 2021. Using data from FFQs before COVID-19, we assessed diet quality using the Alternative Healthy Eating Index (AHEI)-2010, the alternative Mediterranean Diet (AMED) score, an Empirical Dietary Index for Hyperinsulinemia (EDIH), and an Empirical Dietary Inflammatory Pattern (EDIP). We calculated multivariable-adjusted ORs and 95% CIs for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and severity of COVID-19 after controlling for demographic, medical, and lifestyle factors.Among 19,754 participants tested for SARS-CoV-2, 1941 participants reported a positive result. Of these, 1327 reported symptoms needing assistance and another 109 were hospitalized. Healthier diets, represented by higher AHEI-2010 and AMED scores and lower EDIH and EDIP scores, were associated with lower likelihood of SARS-CoV-2 infection (quartile 4 compared with quartile 1: OR: 0.80; 95% CI: 0.69, 0.92 for AHEI-2010; OR: 0.78; 95% CI: 0.67, 0.92 for AMED; OR: 1.36; 95% CI: 1.16, 1.57 for EDIH; and OR: 1.13; 95% CI: 0.99, 1.30 for EDIP; all P-trend ≤ 0.01). In the analysis of COVID-19 severity, participants with healthier diet had lower likelihood of severe infection and were less likely to be hospitalized owing to COVID-19. However, associations were no longer significant after controlling for BMI and pre-existing medical conditions.Diet may be an important modifiable risk factor for SARS-CoV-2 infection, as well as for severity of COVID-19. This association is partially mediated by BMI and pre-existing medical conditions.
- Published
- 2022
7. Incident Early- and Later-Onset Type 2 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study
- Author
-
Yin Zhang, Mingyang Song, Yin Cao, A. Heather Eliassen, Brian M. Wolpin, Meir J. Stampfer, Walter C. Willett, Kana Wu, Kimmie Ng, Frank B. Hu, and Edward L. Giovannucci
- Subjects
Advanced and Specialized Nursing ,Diabetes Mellitus, Type 2 ,Risk Factors ,Neoplasms ,Incidence ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,Humans ,Prospective Studies ,Obesity ,Epidemiology/Health Services Research ,Body Mass Index - Abstract
OBJECTIVE We evaluated prospectively the association between incident early-onset (diagnosed before 40 years of age) and later-onset type 2 diabetes and early-onset (diagnosed before 50 years of age) and later-onset cancer risk. RESEARCH DESIGN AND METHODS We prospectively followed 228,073 eligible participants in the Nurses’ Health Studies for up to 38 years. Hazard ratios (HRs) and 95% CI were estimated using Cox models. RESULTS We documented 18,290 type 2 diabetes, 6,520 early-onset cancer, and 36,907 later-onset cancer cases during follow-up. In fully adjusted analyses, early-onset type 2 diabetes was associated with increased risk of early-onset total cancer (HR [95% CI] 1.47 [1.06–2.04]), diabetes-related cancer (2.11 [1.38–3.23]), and obesity-related cancer (1.75 [1.08–2.82]), and the risk elevations were restricted to those with a BMI at 18 years of age of ≥21 kg/m2 (total cancer: 1.75 [1.20–2.56]; diabetes-related cancer: 2.43 [1.50–3.94]; and obesity-related cancer: 1.84 [1.05–3.22]). Early-onset type 2 diabetes was associated with higher risk of later-onset diabetes-related and obesity-related cancer specifically among individuals with higher BMI at 18 years of age. Later-onset type 2 diabetes was associated with a higher risk of later-onset total cancer (1.15 [1.11–1.20]), diabetes-related cancer (1.17 [1.12–1.22]), and obesity-related cancer (1.18 [1.13–1.24]). In analyses based on refined timing, the HRs attenuated substantially with aging. CONCLUSIONS Incident early-onset type 2 diabetes was associated with increased risk of early-onset total cancer and diabetes- and obesity-related cancer, especially in those with higher BMI at 18 years of age. The impact of early-onset type 2 diabetes on cancer risk may be inherently stronger than that of later-onset type 2 diabetes.
- Published
- 2022
8. Concerns about the Burden of Proof studies
- Author
-
Andrea J. Glenn, Xiao Gu, Frank B. Hu, Molin Wang, and Walter C. Willett
- Subjects
General Medicine ,General Biochemistry, Genetics and Molecular Biology - Published
- 2023
9. Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study
- Author
-
Yin Zhang, Mingyang Song, Andrew T. Chan, Jeffrey A. Meyerhardt, Walter C. Willett, and Edward L. Giovannucci
- Subjects
Angiotensin Receptor Antagonists ,Cancer Research ,Oncology ,Furosemide ,Hypertension ,Adrenergic beta-Antagonists ,Humans ,Prospective Studies ,Calcium Channel Blockers ,Colorectal Neoplasms ,Antihypertensive Agents ,Follow-Up Studies - Abstract
Hypertension and the use of antihypertensive medications have been intensively investigated in relation to colorectal cancer (CRC). Prior epidemiologic studies have not been able to examine this topic with adequate confounding control and follow-up time, or disentangle the effects of antihypertensive agents and hypertension.Eligible participants in the Nurses' Health Study and Health Professionals Follow-up Study were followed for up to 28 years, with repeat assessments of exposures. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals.In fully adjusted analyses based on both new-user and prevalent-user designs, there was no association between the use of beta-blockers, calcium-channel blockers, thiazide diuretics, angiotensin-converting enzyme inhibitors, furosemide, other antihypertensive drugs and CRC risk and mortality reached the statistically significant threshold after Bonferroni correction. The results remained similar in sensitivity analyses among participants with hypertension. Before Bonferroni correction, suggestive associations between beta-blocker use and CRC risk and between furosemide use and CRC-specific mortality were observed specifically in analyses using a new-user design. Hypertension was not associated with CRC risk in analyses based on both new-user and prevalent-user designs.Hypertension and long-term use of major classes of antihypertensive medications are unlikely to be associated with CRC risk and mortality.
- Published
- 2022
10. Egg Consumption and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review and Dose-Response Meta-analysis of Prospective Studies
- Author
-
Seyed Mohammad Mousavi, Nikan Zargarzadeh, Somaye Rigi, Emma Persad, Ana Beatriz Pizarro, Shirin Hasani-Ranjbar, Bagher Larijani, Walter C Willett, and Ahmad Esmaillzadeh
- Subjects
Stroke ,Nutrition and Dietetics ,Cardiovascular Diseases ,Cause of Death ,Neoplasms ,Humans ,Medicine (miscellaneous) ,Coronary Disease ,Review ,Prospective Studies ,Food Science - Abstract
The association between egg consumption and mortality is extremely debatable. This study aimed to investigate the potential dose-response association of egg consumption with risk of mortality from all causes and cause-specific in the general population. The primary comprehensive literature search was conducted in PubMed/Medline, Scopus, ISI Web of Science, and Embase up to March 2021, as well as reference lists of relevant original papers and key journals. We calculated summary RRs and their 95% CIs for the highest and lowest categories, as well as the linear trend estimation of egg intake, using the random-effects model. Thirty-three (32 publications) cohort studies were included. These studies enrolled 2,216,720 participants and recorded 232,408 deaths from all causes. Comparing highest versus lowest egg intake categories was not associated with the risk of mortality from all causes (RR: 1.02; 95% CI: 0.94, 1.11; n = 25), cardiovascular disease (CVD) (RR: 1.04; 95% CI: 0.87, 1.23, n = 11), coronary heart disease (CHD) (RR: 0.98; 95% CI: 0.84, 1.16; n = 10), stroke (RR: 0.81; 95% CI: 0.64, 1.02; n = 9), and respiratory disease (RR: 0.96; 95% CI: 0.53, 1.71; n = 3); however, it was associated with a higher risk of cancer mortality (RR: 1.20; 95% CI: 1.04, 1.39; n = 13). In the linear dose-response analysis, an additional intake of 1 egg per week was associated with a 2% and 4% increased risk of all-cause and cancer mortality, respectively, and a 4% decreased risk of stroke mortality. The certainty of the evidence was rated as low to moderate. Higher egg consumption was not associated with an increased risk of mortality from all causes, CVD, CHD, stroke, or respiratory disease, whereas an elevated risk was observed for cancer mortality. These findings suggest that eggs be consumed in low to moderate amounts (≤1 egg/d) as part of a healthy diet.
- Published
- 2022
11. Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses’ Health Studies
- Author
-
Tengteng Wang, Yujing J. Heng, Gabrielle M. Baker, Vanessa C. Bret-Mounet, Liza M. Quintana, Lisa Frueh, Susan E. Hankinson, Michelle D. Holmes, Wendy Y. Chen, Walter C. Willett, Bernard Rosner, Rulla M. Tamimi, and A. Heather Eliassen
- Subjects
Phosphatidylinositol 3-Kinases ,Receptors, Estrogen ,Oncology ,Class I Phosphatidylinositol 3-Kinases ,Epidemiology ,PTEN Phosphohydrolase ,Humans ,Nurses ,Breast Neoplasms ,Female ,Article - Abstract
Background: The relationships between PTEN loss and/or PIK3CA mutation and breast cancer prognosis remain controversial. We aim to examine the associations in large epidemiologic cohorts. Methods: We followed women with invasive breast cancer from the Nurses’ Health Studies with available data on tumor PTEN expression (n = 4,111) and PIK3CA mutation (n = 2,930). PTEN expression was evaluated by IHC and digitally scored (0%–100%). Pyrosequencing of six hotspot mutations of PIK3CA was performed. Results: We found loss of PTEN expression (≤10%) occurred in 17% of cases, and PIK3CA mutations were detected in 11% of cases. After adjusting for clinical and lifestyle factors, PTEN loss was not associated with worse breast cancer-specific mortality among all samples [HR, 0.85; 95% confidence intervals (CI), 0.71–1.03] or among estrogen receptor (ER)-positive tumors (HR, 0.99; 95% CI, 0.79–1.24). However, among ER-negative tumors, PTEN loss was associated with lower breast cancer-specific mortality (HR, 0.68; 95% CI, 0.48–0.95). PIK3CA mutation was not strongly associated with breast cancer-specific mortality (HR, 0.89; 95% CI, 0.67–1.17). Compared with tumors without PTEN loss and without PIK3CA mutation, those with alterations (n = 540) were not at higher risk (HR, 1.07; 95% CI, 0.86–1.34). However, women with both PTEN loss and PIK3CA mutation (n = 38) were at an increased risk of breast cancer-specific mortality (HR, 1.65; 95% CI, 0.83–3.26). Conclusions: In this large epidemiologic study, the PTEN-mortality association was more pronounced for ER-negative tumors, and the joint PTEN loss and PIK3CA mutation may be associated with worse prognosis. Impact: Further studies with a larger sample of ER-negative tumors are needed to replicate our findings and elucidate underlying mechanisms.
- Published
- 2022
12. Dietary quality and risk of heart failure in men
- Author
-
Xiao Gu, Dong D Wang, Teresa T Fung, Dariush Mozaffarian, Luc Djoussé, Bernard Rosner, Frank M Sacks, and Walter C Willett
- Subjects
Heart Failure ,Male ,Original Research Communications ,Nutrition and Dietetics ,Risk Factors ,Humans ,Medicine (miscellaneous) ,Stroke Volume ,Prognosis ,Ventricular Function, Left ,Diet ,Follow-Up Studies - Abstract
BACKGROUND: Due to the increasing disease burden, strategies to predict and prevent heart failure (HF) are urgently needed. OBJECTIVE: We aimed to investigate whether the Alternative Healthy Eating Index (AHEI) and the clinically abbreviated Prime Diet Quality Score (PDQS) are associated with the risk of overall HF, HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). METHODS: Our study included 44,525 men from the Health Professionals Follow-up Study (HPFS) who were free from cardiovascular disease and cancer at baseline. The AHEI and PDQS were computed based on dietary data repeatedly measured using semiquantitative FFQs. HF, HFpEF, and HFrEF were adjudicated based on review of medical records through 2008. Associations of diet quality with incident HF were estimated with multivariate-adjusted Cox proportional hazards models. RESULTS: During 929,911 person-years of follow-up, 803 HF cases were documented, including 184 with HFpEF and 181 with HFrEF among those with ejection fraction (EF) data. Adjusting for potential confounders, we did not observe a significant association between the AHEI and overall HF (HR (per SD): 0.96; 95% CI: 0.89, 1.04; P-trend = 0.57) or between the PDQS and overall HF (HR (per SD): 0.98; 95% CI: 0.91, 1.06; P-trend = 0.82). Both dietary indices were not significantly associated with HFpEF. However, a higher AHEI was associated with lower risk of HFrEF upon comparison of the extreme quintiles (HR (per SD): 0.81; 95% CI: 0.69, 0.96; P-trend = 0.02). Every SD increment in the PDQS was associated with 20% lower risk of HFrEF (HR (per SD): 0.80; 95% CI: 0.68, 0.95; P-quadratic = 0.03). CONCLUSIONS: A healthy overall diet was associated with lower risk of HFrEF, and associations were similar with the AHEI and PDQS. We did not observe a significant association between dietary indices and either overall HF or HFpEF.
- Published
- 2022
13. Change in habitual intakes of flavonoid-rich foods and mortality in US males and females
- Author
-
Nicola P. Bondonno, Yan Lydia Liu, Yan Zheng, Kerry Ivey, Walter C. Willett, Meir J. Stampfer, Eric B. Rimm, and Aedín Cassidy
- Subjects
General Medicine - Abstract
Background Higher baseline intakes of flavonoid-rich foods and beverages are associated with a lower risk of chronic disease and mortality in observational studies. However, associations between changes in intakes and mortality remain unclear. We aimed to evaluate associations between 8-year changes in intakes of (1) individual flavonoid-rich foods and (2) a composite measure (termed the ‘flavodiet’) of foods and beverages that are known to be main contributors to flavonoid intake and subsequent total and cause-specific mortality. Methods We evaluated associations between 8-year changes in intakes of (1) individual flavonoid-rich foods and (2) a novel ‘flavodiet’ score and total and cause-specific mortality. We included 55,786 females from the Nurses’ Health Study (NHS) and 29,800 males from the Health Professionals Follow-up Study (HPFS), without chronic disease at baseline in our analyses. Using multivariable-adjusted Cox proportional hazard models, we examined associations of 8-year changes in intakes of (1) flavonoid-rich foods and (2) the flavodiet score with subsequent 2-year lagged 6-year risk of mortality adjusting for baseline intakes. Data were pooled using fixed-effects meta-analyses. Results We documented 15,293 deaths in the NHS and 8988 deaths in HPFS between 1986 and 2018. For blueberries, red wine and peppers, a 5%, 4% and 9% lower risk of mortality, respectively, was seen for each 3.5 servings/week increase in intakes while for tea, a 3% lower risk was seen for each 7 servings/week increase [Pooled HR (95% CI) for blueberries; 0.95 (0.91, 0.99); red wine: 0.96 (0.93, 0.99); peppers: 0.91 (0.88, 0.95); and tea: 0.97 (0.95, 0.98)]. Conversely, a 3.5 servings/week increase in intakes of onions and grapefruit plus grapefruit juice was associated with a 5% and 6% higher risk of total mortality, respectively. An increase of 3 servings per day in the flavodiet score was associated with an 8% lower risk of total mortality [Pooled HR: 0.92 (0.89, 0.96)], and a 13% lower risk of neurological mortality [Pooled HR: 0.87 (0.79, 0.97)], after multivariable adjustments. Conclusions Encouraging an increased intake of specific flavonoid-rich foods and beverages, namely tea, blueberries, red wine, and peppers, even in middle age, may lower early mortality risk.
- Published
- 2023
14. Validation of the rapid Prime Diet Quality Score screener (rPDQS), a brief dietary assessment tool with simple traffic light scoring
- Author
-
Selma Kronsteiner-Gicevic, Monique Tello, L. Elizabeth Lincoln, Jordan K. Kondo, Uma Naidoo, Teresa T. Fung, Walter C. Willett, and Anne N. Thorndike
- Subjects
Nutrition and Dietetics ,General Medicine ,Food Science - Published
- 2023
15. Alcohol consumption and risk of total hip replacement due to hip osteoarthritis in women
- Author
-
Nathalie E. Marchand, Yang Hu, Mingyang Song, Bernard A. Rosner, Elizabeth W. Karlson, Charles Ratzlaff, Bing Lu, Matthew H. Liang, and Walter C. Willett
- Subjects
Rheumatology ,Immunology ,Immunology and Allergy - Published
- 2023
16. Sugar- or artificially-sweetened beverage consumption, physical activity, and risk of cardiovascular disease in US adults
- Author
-
Lorena S. Pacheco, Deirdre K. Tobias, Yanping Li, Shilpa N. Bhupathiraju, Walter C. Willett, David S. Ludwig, Cara B. Ebbeling, Danielle E. Haslam, Jean-Philippe Drouin-Chartier, Frank B. Hu, and Marta Guasch-Ferré
- Subjects
Article - Abstract
BackgroundThe extent to which physical activity attenuates the detrimental effects of sugar (SSBs)- or artificially-sweetened beverages (ASBs) on the risk of cardiovascular disease is unknown.MethodsWe used Cox proportional-hazards models to calculate hazard ratios and 95% confidence interval [HR (CI)] between SSB or ASB intake and physical activity with cardiovascular disease risk among 65,730 women in the Nurses’ Health Study (1980-2016) and 39,418 men in the Health Professional’s Follow-up Study (1986-2016), who were free from chronic diseases at baseline. SSBs and ASBs were assessed every 4-years and physical activity biannually.ResultsA total of 13,269 cardiovascular events were ascertained during 3,001,213 person-years of follow-up. Compared with those that never/rarely consumed SSBs or ASBs, HR and 95% CI for cardiovascular disease for participants consuming ≥2 servings/day were 1.21 (95% CI,1.12 to 1.32;P-trendP-trend=0.06), respectively. In the joint analyses, for participants meeting and not meeting physical activity guidelines (ConclusionsOur findings suggest that among physically active participants, higher SSB intake, but not ASBs, is associated with a higher cardiovascular risk. Our results support current recommendations to limit the intake of SSB and maintain adequate physical activity levels.Clinical PerspectiveWhat is new?Consumption of sugar- or artificially-sweetened beverages and physical activity are independently associated with cardiovascular disease; nevertheless, the role that physical activity plays in the associations between sugar- and artificially-sweetened beverages consumption and cardiovascular disease warrants further analysis since physical activity could offset the health risk that would have been induced by their consumption.In two US cohorts, not meeting physical activity guidelines jointly with a greater intake of sugar- or artificially-sweetened beverages was associated with a higher risk of cardiovascular disease; however, even when individuals were physically active, higher consumption of sugar-sweetened beverages was associated with a higher cardiovascular risk.What are the clinical implications?Our results provide further evidence of the intake of sugar-sweetened beverages and low physical activity as factors negatively impacting cardiovascular health.Our results support public health recommendations and policies to limit the intake of sugar-sweetened beverages and meet and maintain adequate physical activity levels.
- Published
- 2023
17. Data from Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies
- Author
-
Rulla M. Tamimi, Walter C. Willett, Karin B. Michels, A. Heather Eliassen, Bernard Rosner, Stuart Schnitt, Andrew H. Beck, Laura C. Collins, Rong Hu, and Erica T. Warner
- Abstract
Height and body size in childhood and young adulthood have been consistently associated with breast cancer risk; whether associations differ across molecular subtypes is unclear. In a pooled analysis of the Nurses' Health Studies, we prospectively examined the association of four exposures: height, body mass index (BMI) at the age of 18 years, childhood and adolescent somatotypes, with breast cancer risk according to molecular subtypes defined by immunohistochemical markers. We used multivariable-adjusted Cox proportional hazards regression to estimate HRs and 95% confidence intervals (CI). We identified 2,983 luminal A, 1,281 luminal B, 318 HER2-enriched, 408 basal-like, and 128 unclassified tumors. Height was positively associated with all subtypes (Pheterogeneity = 0.78). BMI at the age of 18 (Pheterogeneity = 0.001), childhood (Pheterogeneity = 0.51), and adolescent somatotype (Pheterogeneity = 0.046) were inversely associated, but with differences in magnitude of association. BMI at the age of 18 of ≥25 kg/m2 (compared with 20–21.9 kg/m2) was associated with a 52% decreased risk of HER2-enriched (HR, 0.48; 95% CI, 0.26–0.91; Ptrend < 0.0001) and 39% reduced risk of basal-like tumors (HR, 0.61; 95% CI, 0.36–1.02; Ptrend = 0.008). Compared with the lowest category, women in the highest adolescent body size category were 71% less likely to develop HER2-enriched (HR, 0.29; 95% CI, 0.10–0.85; Ptrend = 0.0005) and 60% less likely to develop basal-like (HR, 0.40; 95% CI, 0.17–0.95; Ptrend = 0.0008). Height was positively associated with risk of all breast cancer molecular subtypes. BMI at 18 years and childhood and adolescent were inversely associated with risk of most breast cancer molecular subtypes with somewhat stronger associations with HER2-enriched and basal-like subtypes. Cancer Prev Res; 9(9); 732–8. ©2016 AACR.
- Published
- 2023
18. Data from Adulthood Weight Change and Risk of Colorectal Cancer in the Nurses' Health Study and Health Professionals Follow-up Study
- Author
-
Edward L. Giovannucci, Walter C. Willett, Charles S. Fuchs, Shuji Ogino, Kana Wu, Andrew T. Chan, Donna Spiegelman, Frank B. Hu, and Mingyang Song
- Abstract
We investigated the association between adulthood weight change and colorectal cancer risk in a prospective study with 24 to 34 years of follow-up among 90,988 women and 46,679 men. The primary exposures included weight change from early adulthood (age = 18 years for women, 21 years for men) to baseline enrollment (median age = 43 years for women, 52 years for men), and from baseline to present. In the secondary analyses, we also assessed 4-year weight change during follow-up, and during premenopausal (from age 18 years to menopause) and postmenopausal (from menopause to present) periods in women. Compared to men maintaining their weight from age 21 to baseline, those who gained 20 kg or more were at a higher risk of colorectal cancer (relative risk [RR], 1.64; 95% confidence interval [CI], 1.15–2.35, Ptrend < 0.001), whereas those who lost 8 kg or more had a lower risk (RR, 0.61; 95% CI, 0.30–1.22, Ptrend = 0.003). Similar but weaker associations were found in women and the corresponding RRs were 1.38 (95% CI, 1.13–1.69, Ptrend < 0.001) and 0.80 (95% CI, 0.58–1.09, Ptrend = 0.21). Weight change from baseline to present was not associated with colorectal cancer risk. Four-year weight change during follow-up was positively associated with colorectal cancer risk in men (Ptrend = 0.03) but not in women (Ptrend = 0.42). In addition, in women, weight change before, but not after, menopause was associated with colorectal cancer risk. Our findings provide further scientific rationale for recommendations to maintain a healthy body weight during adulthood. A potential differential association according to sex and timing of weight change warrants further investigation. Cancer Prev Res; 8(7); 620–7. ©2015 AACR.
- Published
- 2023
19. Supplementary tables from Dietary Intake of Branched-Chain Amino Acids and Risk of Colorectal Cancer
- Author
-
Kana Wu, Edward Giovannucci, Walter C. Willett, Shuji Ogino, Motoki Iwasaki, Amit D. Joshi, Andrew T. Chan, Reiko Nishihara, Jeffrey A. Meyerhardt, Charles S. Fuchs, Fred K. Tabung, Dong Hoon Lee, Xuehong Zhang, Mingyang Song, and Ryoko Katagiri
- Abstract
supplemental table
- Published
- 2023
20. Supplementary tables from Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies
- Author
-
Rulla M. Tamimi, Walter C. Willett, Karin B. Michels, A. Heather Eliassen, Bernard Rosner, Stuart Schnitt, Andrew H. Beck, Laura C. Collins, Rong Hu, and Erica T. Warner
- Abstract
Tables 1 and 2 display estimates for height, BMI at age 18 and somatotypes for pre and postmenopausal women. Table 3 contains estimates for triple negative tumors for all four exposures.
- Published
- 2023
21. Supplementary methods and tables 1-7 from Adulthood Weight Change and Risk of Colorectal Cancer in the Nurses' Health Study and Health Professionals Follow-up Study
- Author
-
Edward L. Giovannucci, Walter C. Willett, Charles S. Fuchs, Shuji Ogino, Kana Wu, Andrew T. Chan, Donna Spiegelman, Frank B. Hu, and Mingyang Song
- Abstract
Supplementary methods and tables 1-7. Supplementary Methods: Covariate assessment and statistical analysis Supplementary Table 1. Relative risk of colorectal cancer by body mass index according to weight change from age 18 (women) or 21 (men) years to baseline Supplementary Table 2. Relative risk of colorectal cancer by baseline age according to weight change from age 18 (women) or 21 (men) years to baseline Supplementary Table 3. Subsite-specific relative risk of colorectal cancer according to weight change from age 18 (women) or 21 (men) years to baseline Supplementary Table 4. Relative risk of colorectal cancer by baseline use of aspirin according to weight change from age 18 (women) or 21 (men) years to baseline Supplementary Table 5. Relative risk of colorectal cancer by current age according to weight change from baseline to present Supplementary Table 6. Relative risk of colorectal cancer by current age according to 4-year weight change during follow-up Supplementary Table 7. Relative risk of colorectal cancer by postmenopausal hormone use according to postmenopausal weight change
- Published
- 2023
22. Data from Dietary Intake of Branched-Chain Amino Acids and Risk of Colorectal Cancer
- Author
-
Kana Wu, Edward Giovannucci, Walter C. Willett, Shuji Ogino, Motoki Iwasaki, Amit D. Joshi, Andrew T. Chan, Reiko Nishihara, Jeffrey A. Meyerhardt, Charles S. Fuchs, Fred K. Tabung, Dong Hoon Lee, Xuehong Zhang, Mingyang Song, and Ryoko Katagiri
- Abstract
Branched-chain amino acids (BCAA) are essential amino acids, and emerging evidence suggests that BCAAs may mediate pathways related to cancer progression, possibly due to their involvement in insulin metabolism. We investigated the association between dietary intake of BCAAs with colorectal cancer risk in three prospective cohorts: the Nurses' Health Study I [(NHS), number of participants (n) at baseline = 77,017], NHS II (n = 92,984), and the Health Professionals Follow-up Study [(HPFS) n = 47,255]. Validated food frequency questionnaires were administered every 4 years and follow-up questionnaires on lifestyle biennially. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using Cox proportional hazards regression models. Pooled HRs were obtained using random effect models. After up to 28 years of follow-up, 1,660 cases were observed in NHS, 306 in NHS II, and 1,343 in HPFS. In multivariable adjusted models, we observed a weak inverse association between BCAA intake and colorectal cancer [highest vs. lowest quintile, pooled HR including all three cohorts (95% CI): 0.89 (0.80–1.00), Ptrend = 0.06, HR per standard deviation (SD) increment 0.95 (0.92–0.99)]. However, after including dairy calcium to the models, BCAA intake was no longer associated with risk of colorectal cancer [HR 0.96 (0.85–1.08), Ptrend = 0.50, HR per SD increment 0.97 (0.93–1.01)]. We did not find evidence that higher dietary BCAA intake is associated with higher risk of colorectal cancer. As this is the first prospective study to examine the association between BCAA intake and colorectal cancer, our findings warrant investigation in other cohorts.
- Published
- 2023
23. Data from Tobacco and Alcohol in Relation to Male Breast Cancer: An Analysis of the Male Breast Cancer Pooling Project Consortium
- Author
-
Louise A. Brinton, Walter C. Willett, David B. Thomas, Anthony Swerdlow, Howard D. Sesso, Elio Riboli, Eleni Th. Petridou, Dominick Parisi, Håkan Olsson, Eva Negri, Valerie A. McCormack, Jay H. Lubin, Elsebeth Lynge, Carlo La Vecchia, Laurence N. Kolonel, Kenneth Johnson, Ann W. Hsing, Laurel A. Habel, George Gkiokas, Mia M. Gaudet, Roni T. Falk, Marianne Ewertz, Stephen K. Van Den Eeden, Rosie Cooke, John T. Casagrande, Karin B. Michels, Piet A. van den Brandt, Susan M. Gapstur, Pascal Guénel, and Michael B. Cook
- Abstract
Background: The etiology of male breast cancer is poorly understood, partly due to its relative rarity. Although tobacco and alcohol exposures are known carcinogens, their association with male breast cancer risk remains ill-defined.Methods: The Male Breast Cancer Pooling Project consortium provided 2,378 cases and 51,959 controls for analysis from 10 case–control and 10 cohort studies. Individual participant data were harmonized and pooled. Unconditional logistic regression was used to estimate study design–specific (case–control/cohort) ORs and 95% confidence intervals (CI), which were then combined using fixed-effects meta-analysis.Results: Cigarette smoking status, smoking pack-years, duration, intensity, and age at initiation were not associated with male breast cancer risk. Relations with cigar and pipe smoking, tobacco chewing, and snuff use were also null. Recent alcohol consumption and average grams of alcohol consumed per day were also not associated with risk; only one subanalysis of very high recent alcohol consumption (>60 g/day) was tentatively associated with male breast cancer (ORunexposed referent = 1.29; 95% CI, 0.97–1.71; OR>0– = 1.36; 95% CI, 1.04–1.77). Specific alcoholic beverage types were not associated with male breast cancer. Relations were not altered when stratified by age or body mass index.Conclusions: In this analysis of the Male Breast Cancer Pooling Project, we found little evidence that tobacco and alcohol exposures were associated with risk of male breast cancer.Impact: Tobacco and alcohol do not appear to be carcinogenic for male breast cancer. Future studies should aim to assess these exposures in relation to subtypes of male breast cancer. Cancer Epidemiol Biomarkers Prev; 24(3); 520–31. ©2014 AACR.
- Published
- 2023
24. Supplementary Table 3 from Tobacco and Alcohol in Relation to Male Breast Cancer: An Analysis of the Male Breast Cancer Pooling Project Consortium
- Author
-
Louise A. Brinton, Walter C. Willett, David B. Thomas, Anthony Swerdlow, Howard D. Sesso, Elio Riboli, Eleni Th. Petridou, Dominick Parisi, Håkan Olsson, Eva Negri, Valerie A. McCormack, Jay H. Lubin, Elsebeth Lynge, Carlo La Vecchia, Laurence N. Kolonel, Kenneth Johnson, Ann W. Hsing, Laurel A. Habel, George Gkiokas, Mia M. Gaudet, Roni T. Falk, Marianne Ewertz, Stephen K. Van Den Eeden, Rosie Cooke, John T. Casagrande, Karin B. Michels, Piet A. van den Brandt, Susan M. Gapstur, Pascal Guénel, and Michael B. Cook
- Abstract
Supplementary Table 3. Associations between alcohol consumption exposures and male breast cancer risk
- Published
- 2023
25. Supplementary Data from Diabetes Risk Reduction Diet and Survival after Breast Cancer Diagnosis
- Author
-
A. Heather Eliassen, Walter C. Willett, Rulla M. Tamimi, Bernard A. Rosner, Michelle D. Holmes, Jae H. Kang, Maryam S. Farvid, and Tengteng Wang
- Abstract
Supplementary Table 1 and 2
- Published
- 2023
26. Supplementary Table 2 and Supplemental Figures from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
- Author
-
Rayjean J. Hung, Brian E. Henderson, Christopher A. Haiman, David J. Hunter, Douglas F. Easton, Thomas A. Sellers, Christopher I. Amos, Stephen B. Gruber, Ulrike Peters, Jian Gong, Stephen J. Chanock, Daniela Seminara, Qiyuan Li, Matthew L. Freedman, Wim Timens, David Nickle, Ma'en Obeidat, Yohan Bossé, Atsushi Takahashi, Kouya Shiraishi, Xiao-Ou Shu, Zhibin Hu, Hongbing Shen, Yongyue Wei, David C. Christiani, Jonathan P. Tyrer, Y. Ann Chen, Patrick Sulem, Kari Stefansson, Simon N. Stacey, Julius Gudmundsson, Thorunn Rafnar, Michael O. Woods, Stephen N. Thibodeau, Stephanie L. Schmit, Noralene M. Lindor, Li Li, Loïc Le Marchand, Mark Jenkins, Robert W. Haile, Steven Gallinger, Christopher K. Edlund, David V. Conti, Graham Casey, Daniel D. Buchanan, Wei Zheng, Xiaohong R. Yang, Alice S. Whittemore, Zhaoming Wang, Andre G. Uitterlinden, Clare Turnbull, Ruth C. Travis, Rulla Tamimi, Melissa C. Southey, Rita K. Schmutzler, Daniel F. Schmidt, Maria Jose Sanchez, Nazneen Rahman, Ross L. Prentice, Julian Peto, Petra H. Peeters, Heli Nevanlinna, Taru A. Muranen, Bertram Müller-Myhsok, Alfons Meindl, Enes Makalic, Eiliv Lund, Jianjun Liu, Peter Lichtner, Muhammad G. Kibriya, Rudolf Kaaks, Mattias Johansson, Astrid Irwanto, John L. Hopper, Albert Hofman, Rebecca Hein, Aditi Hazra, Per Hall, Nichola Johnson, Mia M. Gaudet, Montserrat Garcia-Closas, Olivia Fletcher, Dieter Flesch-Janys, Jonine D. Figueroa, A. Heather Eliassen, Isabel dos-Santos-Silva, Kamila Czene, Federico Canzian, Carl Blomquist, Laura Baglietto, Kristiina Aittomäki, Habibul Ahsan, Muriel A. Adank, Emily White, Martha L. Slattery, Robert E. Schoen, Polly A. Newcomb, Jonathan K. Kocarnik, Thomas J. Hudson, Jenny Chang-Claude, Andrew T. Chan, Hermann Brenner, Stephane Bezieau, Brett M. Reid, Harvey A. Risch, Jennifer B. Permuth, Ellen L. Goode, Walter C. Willett, Fredrik Wiklund, Victoria L. Stevens, Meir J. Stampfer, Kenneth Muir, Jing Ma, Zsofia Kote-Jarai, Henrik Grönberg, Edward L. Giovannucci, Sonja I. Berndt, Ali Amin Al Olama, Angela Risch, Neil Caporaso, Maria Teresa Landi, Richard S. Houlston, Heike Bickeböller, Paul Brennan, Sara Lindström, Joellen M. Schildkraut, Fredrick R. Schumacher, Nilanjan Chatterjee, Rosalind A. Eeles, Paul D. Pharoah, Peter Kraft, and Gordon Fehringer
- Abstract
Table S2: Odds ratio and 95% confidence limits for cancers associated with variants with pleiotropic associations. Figure S1: Flowchart showing analysis steps. Figure S2. Manhattan plots by chromosome for individual cancer sites. Figure S3. Results for rs11571833. Figure S4: Conditional QQ-plots.
- Published
- 2023
27. Data from Diabetes Risk Reduction Diet and Survival after Breast Cancer Diagnosis
- Author
-
A. Heather Eliassen, Walter C. Willett, Rulla M. Tamimi, Bernard A. Rosner, Michelle D. Holmes, Jae H. Kang, Maryam S. Farvid, and Tengteng Wang
- Abstract
Type II diabetes is associated with poor breast cancer prognosis. To study the association between a diabetes risk reduction diet (DRRD) and survival following breast cancer, we followed 8,482 women with breast cancer from two large cohort studies. Information on diet and other factors was repeatedly measured in validated questionnaires every two to four years. The DRRD includes 9 components: higher intakes of cereal fiber, coffee, nuts, whole fruits and polyunsaturated/saturated fat ratio; and lower glycemic index, trans fat, sugar-sweetened beverages, and red meat. Cumulative average DRRD score was calculated using repeated measures of postdiagnostic diet. Deaths were assessed by family members or via National Death Index. Multivariable-adjusted HRs and 95% confidence intervals (CI) were estimated using Cox proportional hazards models. During a median of 14 years of follow-up since diagnosis, 2,600 deaths occurred among participants, 1,042 of which were due to breast cancer. Women with higher postdiagnostic DRRD score had a 20% lower risk of breast cancer–specific mortality (top vs. bottom quintile HR = 0.80; 95% CI = 0.65–0.97; Ptrend = 0.02) and 34% lower risk of all-cause mortality (HR = 0.66; 95% CI = 0.58–0.76; Ptrend < 0.0001). Compared with women who consistently had lower score (≤median) before and after diagnosis, those whose score improved from low to high had a lower risk of breast cancer–specific mortality (HR = 0.77; 95% CI = 0.62–0.95) and overall mortality (HR = 0.85; 95% CI = 0.74–0.97). These findings demonstrate that greater adherence to DRRD was associated with better survival, suggesting postdiagnosis dietary modification consistent with type II diabetes prevention may be important for breast cancer survivors.Significance:This study suggests that greater adherence to the diabetes risk reduction diet after diagnosis associates with improved survival outcomes among a large number of breast cancer survivors.
- Published
- 2023
28. Data from Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
- Author
-
Peter Kraft, Stephen J. Chanock, Christopher A. Haiman, Gianluca Severi, Richard B. Hayes, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Dimitrios Trichopoulos, Anne Tjonneland, Michael J. Thun, Daniel O. Stram, Meir Stampfer, Valeria Pala, Loïc Le Marchand, Jing Ma, Laurence N. Kolonel, Mattias Johansson, David J. Hunter, Brian Henderson, Carlos A. Gonzalez, Edward Giovannucci, Graham G. Giles, J. Michael Gaziano, W. Ryan Diver, E. David Crawford, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Gerald Andriole, Naomi E. Allen, Demetrius Albanes, Ruth C. Travis, David Cox, Fredrick R. Schumacher, and Sara Lindström
- Abstract
Background: One of the goals of personalized medicine is to generate individual risk profiles that could identify individuals in the population that exhibit high risk. The discovery of more than two-dozen independent single-nucleotide polymorphism markers in prostate cancer has raised the possibility for such risk stratification. In this study, we evaluated the discriminative and predictive ability for prostate cancer risk models incorporating 25 common prostate cancer genetic markers, family history of prostate cancer, and age.Methods: We fit a series of risk models and estimated their performance in 7,509 prostate cancer cases and 7,652 controls within the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). We also calculated absolute risks based on SEER incidence data.Results: The best risk model (C-statistic = 0.642) included individual genetic markers and family history of prostate cancer. We observed a decreasing trend in discriminative ability with advancing age (P = 0.009), with highest accuracy in men younger than 60 years (C-statistic = 0.679). The absolute ten-year risk for 50-year-old men with a family history ranged from 1.6% (10th percentile of genetic risk) to 6.7% (90th percentile of genetic risk). For men without family history, the risk ranged from 0.8% (10th percentile) to 3.4% (90th percentile).Conclusions: Our results indicate that incorporating genetic information and family history in prostate cancer risk models can be particularly useful for identifying younger men that might benefit from prostate-specific antigen screening.Impact: Although adding genetic risk markers improves model performance, the clinical utility of these genetic risk models is limited. Cancer Epidemiol Biomarkers Prev; 21(3); 437–44. ©2012 AACR.
- Published
- 2023
29. Data from Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer
- Author
-
Walter C. Willett, Wendy Y. Chen, Eunyoung Cho, A. Heather Eliassen, and Maryam S. Farvid
- Abstract
Background: Carcinogenic exposure in early life may be critical for subsequent breast cancer risk. Dairy consumption was examined during adolescence and early adulthood in relation to incident breast cancer in the Nurses' Health Study II cohort.Methods: For the analyses of early adulthood dairy consumption, we included 90,503 premenopausal women ages 27 to 44 years in 1991 who reported dairy consumption using a validated food-frequency questionnaire. From 1991 to 2013, 3,191 invasive breast cancer cases were identified. In 1998, 44,264 women recalled adolescent dairy consumption. This subgroup of women was followed up from 1998 to 2013; 1,318 invasive breast cancer cases were identified. Multivariate hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using the Cox proportional hazard regression.Results: Adolescent and early adulthood total dairy consumption was not associated with overall breast cancer risk (each serving/day during adolescence, total dairy HR = 1.02, 95% CI, 0.97–1.07; for early adulthood total dairy HR = 1.01, 95% CI, 0.97–1.04), as were intakes of calcium, vitamin D, and lactose. Adolescent consumption of total and high-fat dairy was associated with higher risk of estrogen and progesterone receptor negative (each serving/day: total dairy HR = 1.11, 95% CI, 1.00–1.24; high-fat dairy HR = 1.17, 95% CI, 1.04–1.31). However, higher adolescent high-fat dairy consumption was associated with lower risk of estrogen and progesterone receptor positive tumors (each serving/day HR = 0.91, 95% CI, 0.86–0.97).Conclusions: Our results suggest no overall association between dairy consumption during adolescence or early adulthood and breast cancer risk, but the findings may differ by hormone receptor status of tumors.Impact: Dairy consumption in adolescence or early adulthood may not be a significant predictor of breast cancer incidence. Cancer Epidemiol Biomarkers Prev; 27(5); 575–84. ©2018 AACR.
- Published
- 2023
30. Data from Alcohol Consumption in Relation to Plasma Sex Hormones, Prolactin, and Sex Hormone–Binding Globulin in Premenopausal Women
- Author
-
A. Heather Eliassen, Susan E. Hankinson, Walter C. Willett, Donna Spiegelman, and Kelly A. Hirko
- Abstract
Background: Alcohol consumption is a consistent risk factor for breast cancer, and evidence suggests premenopausal plasma hormones are associated with breast cancer.Methods: Plasma concentrations of estradiol, estrone, estrone sulfate, testosterone, androstenedione, progesterone, prolactin, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), and sex hormone–binding globulin (SHBG) were measured in samples collected in 1996–99. Average alcohol intake was calculated from semiquantitative food frequency questionnaires collected in 1995 and 1999. We used generalized linear models to calculate geometric mean hormone concentrations across alcohol categories and the percentage difference for the highest versus lowest category.Results: Comparing women who consumed >20 g/d with nondrinkers, levels were 25.7% higher for luteal estrone (geometric mean, 106 vs. 84.5 pg/mL; Ptrend = 0.001), 27.2% higher for luteal estradiol (182 vs. 143 pg/mL; Ptrend = 0.006), and 16.8% higher for SHBG (85.6 vs. 73.3 nmol/L; Ptrend = 0.03); concentrations of free testosterone were 17.9% lower (0.16 vs. 0.20 ng/dL; Ptrend = 0.002). Women consuming >10 g/d compared with nondrinkers had 26.5% higher concentrations of follicular estrone sulfate (950 vs. 751 pg/mL; Ptrend = 0.04). We did not observe significant associations between alcohol and the other sex hormones evaluated. Significant positive associations were observed with beer intake, but not other alcohol types, for DHEA (Pinteraction = 0.003) and androstenedione (Pinteraction = 0.006).Conclusion: Alcohol consumption was significantly positively associated with plasma luteal estrogen concentrations, but not with androgen levels, nor estrone or estradiol measured in the follicular phase.Impact: Differences in premenopausal estrogen levels may contribute to the association between alcohol and breast cancer. Cancer Epidemiol Biomarkers Prev; 23(12); 2943–53. ©2014 AACR.
- Published
- 2023
31. Supplementary Table 2 from Tobacco and Alcohol in Relation to Male Breast Cancer: An Analysis of the Male Breast Cancer Pooling Project Consortium
- Author
-
Louise A. Brinton, Walter C. Willett, David B. Thomas, Anthony Swerdlow, Howard D. Sesso, Elio Riboli, Eleni Th. Petridou, Dominick Parisi, Håkan Olsson, Eva Negri, Valerie A. McCormack, Jay H. Lubin, Elsebeth Lynge, Carlo La Vecchia, Laurence N. Kolonel, Kenneth Johnson, Ann W. Hsing, Laurel A. Habel, George Gkiokas, Mia M. Gaudet, Roni T. Falk, Marianne Ewertz, Stephen K. Van Den Eeden, Rosie Cooke, John T. Casagrande, Karin B. Michels, Piet A. van den Brandt, Susan M. Gapstur, Pascal Guénel, and Michael B. Cook
- Abstract
Supplementary Table 2. Associations between tobacco exposures and male breast cancer risk additionally adjusted for total exposure (pack-years)
- Published
- 2023
32. Data from Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses' Health Studies
- Author
-
A. Heather Eliassen, Walter C. Willett, Rulla M. Tamimi, Bernard A. Rosner, Wendy Y. Chen, Michelle D. Holmes, and Maryam S. Farvid
- Abstract
Fruits and vegetables contain many bioactive components that may contribute to improved survival after diagnosis of breast cancer, however, evidence to date is insufficient. We prospectively assessed the associations of postdiagnostic fruit and vegetable consumption with breast cancer–specific and all-cause mortality among 8,927 women with stage I–III breast cancer identified during follow-up of the Nurses' Health Study (NHS; 1980–2010) and NHSII (1991–2011), using a validated food frequency questionnaire completed every 4 years after diagnosis. We prospectively documented 2,521 deaths, including 1,070 from breast cancer through follow-up until 2014 in the NHS and 2015 in the NHSII. Total fruit and vegetable and total vegetable consumption was related to lower all-cause [HRQ5vsQ1, 0.82; 95% confidence interval (CI), 0.71–0.94; Ptrend = 0.004, and HRQ5vsQ1, 0.84; 95% CI, 0.72–0.97; Ptrend = 0.001, respectively], but not breast cancer–specific mortality. Total fruit consumption was not related to breast cancer–specific or all-cause mortality. Greater intake of green leafy and cruciferous vegetables was associated with lower all-cause mortality. Each 2 servings/week of blueberries was associated with a 25% (HR, 0.75; 95% CI, 0.60–0.94) lower breast cancer–specific and a 17% (HR, 0.83; 95% CI, 0.72–0.96) lower all-cause mortality. In contrast, higher fruit juice consumption was associated with higher breast cancer–specific (HRQ5vsQ1, 1.33; 95% CI, 1.09–1.63; Ptrend = 0.002) and all-cause mortality (HRQ5vsQ1, 1.19; 95% CI, 1.04–1.36; Ptrend = 0.003). Apple juice largely accounted for these higher risks and orange juice was not associated with risk. Higher postdiagnostic fruit and vegetable consumption among breast cancer survivors was not associated with breast cancer–specific mortality. However, our findings suggest that higher vegetable consumption, particularly green leafy and cruciferous vegetables, was associated with better overall survival among patients with breast cancer. Higher fruit juice consumption, but not orange juice, was associated with poorer breast cancer–specific and all-cause survival.Significance:A large-scale study shows that high fruit and vegetable consumption may be associated with better overall survival among breast cancer patients, while high fruit juice consumption may be associated with poorer porgnosis.
- Published
- 2023
33. Supplementary Tables 1-8 from Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
- Author
-
Peter Kraft, Stephen J. Chanock, Christopher A. Haiman, Gianluca Severi, Richard B. Hayes, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Dimitrios Trichopoulos, Anne Tjonneland, Michael J. Thun, Daniel O. Stram, Meir Stampfer, Valeria Pala, Loïc Le Marchand, Jing Ma, Laurence N. Kolonel, Mattias Johansson, David J. Hunter, Brian Henderson, Carlos A. Gonzalez, Edward Giovannucci, Graham G. Giles, J. Michael Gaziano, W. Ryan Diver, E. David Crawford, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Gerald Andriole, Naomi E. Allen, Demetrius Albanes, Ruth C. Travis, David Cox, Fredrick R. Schumacher, and Sara Lindström
- Abstract
PDF file - 169K
- Published
- 2023
34. Supplementary Figure 1 from Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
- Author
-
Peter Kraft, Stephen J. Chanock, Christopher A. Haiman, Gianluca Severi, Richard B. Hayes, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Dimitrios Trichopoulos, Anne Tjonneland, Michael J. Thun, Daniel O. Stram, Meir Stampfer, Valeria Pala, Loïc Le Marchand, Jing Ma, Laurence N. Kolonel, Mattias Johansson, David J. Hunter, Brian Henderson, Carlos A. Gonzalez, Edward Giovannucci, Graham G. Giles, J. Michael Gaziano, W. Ryan Diver, E. David Crawford, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Gerald Andriole, Naomi E. Allen, Demetrius Albanes, Ruth C. Travis, David Cox, Fredrick R. Schumacher, and Sara Lindström
- Abstract
PDF file - 71K
- Published
- 2023
35. Data from Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
- Author
-
Peter Kraft, Regina G. Ziegler, Elio Riboli, Rudolf Kaaks, Shumin M. Zhang, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Rosario Tumino, Dimitrios Trichopoulos, Anne Tjønneland, Michael J. Thun, Gilles Thomas, Daniel O. Stram, Pär Stattin, Meir J. Stampfer, Maria-José Sánchez, Carlotta Sacerdote, Laudina Rodriguez, Kim Overvad, N. Charlotte Onland-Moret, Jing Ma, Eiliv Lund, Loic LeMarchand, I-Min Lee, Pagona Lagiou, Laurence N. Kolonel, Kay-Tee Khaw, Timothy J. Key, Mattias Johansson, Robert N. Hoover, David J. Hunter, Brian E. Henderson, Richard B. Hayes, Susan E. Hankinson, Christopher A. Haiman, Edward L. Giovannucci, J. Michael Gaziano, Vanessa Dumeaux, Françoise Clavel-Chapelon, Stephen J. Chanock, Nathalie Chabbert-Buffet, Julie E. Buring, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Christine D. Berg, Demetrius Albanes, Naomi E. Allen, Federico Canzian, Fredrick R. Schumacher, and Fangyi Gu
- Abstract
Background: Circulating levels of insulin-like growth factor I (IGF-I) and its main binding protein, IGF binding protein 3 (IGFBP-3), have been associated with risk of several types of cancer. Heritable factors explain up to 60% of the variation in IGF-I and IGFBP-3 in studies of adult twins.Methods: We systematically examined common genetic variation in 18 genes in the IGF signaling pathway for associations with circulating levels of IGF-I and IGFBP-3. A total of 302 single nucleotide polymorphisms (SNP) were genotyped in >5,500 Caucasian men and 5,500 Caucasian women from the Breast and Prostate Cancer Cohort Consortium.Results: After adjusting for multiple testing, SNPs in the IGF1 and SSTR5 genes were significantly associated with circulating IGF-I (P < 2.1 × 10−4); SNPs in the IGFBP3 and IGFALS genes were significantly associated with circulating IGFBP-3. Multi-SNP models explained R2 = 0.62% of the variation in circulating IGF-I and 3.9% of the variation in circulating IGFBP-3. We saw no significant association between these multi-SNP predictors of circulating IGF-I or IGFBP-3 and risk of prostate or breast cancers.Conclusion: Common genetic variation in the IGF1 and SSTR5 genes seems to influence circulating IGF-I levels, and variation in IGFBP3 and IGFALS seems to influence circulating IGFBP-3. However, these variants explain only a small percentage of the variation in circulating IGF-I and IGFBP-3 in Caucasian men and women.Impact: Further studies are needed to explore contributions from other genetic factors such as rare variants in these genes and variation outside of these genes. Cancer Epidemiol Biomarkers Prev; 19(11); 2877–87. ©2010 AACR.
- Published
- 2023
36. Supplementary Table 1 from Tobacco and Alcohol in Relation to Male Breast Cancer: An Analysis of the Male Breast Cancer Pooling Project Consortium
- Author
-
Louise A. Brinton, Walter C. Willett, David B. Thomas, Anthony Swerdlow, Howard D. Sesso, Elio Riboli, Eleni Th. Petridou, Dominick Parisi, Håkan Olsson, Eva Negri, Valerie A. McCormack, Jay H. Lubin, Elsebeth Lynge, Carlo La Vecchia, Laurence N. Kolonel, Kenneth Johnson, Ann W. Hsing, Laurel A. Habel, George Gkiokas, Mia M. Gaudet, Roni T. Falk, Marianne Ewertz, Stephen K. Van Den Eeden, Rosie Cooke, John T. Casagrande, Karin B. Michels, Piet A. van den Brandt, Susan M. Gapstur, Pascal Guénel, and Michael B. Cook
- Abstract
Supplementary Table 1. Characteristics of the Studies Included in the Male Breast Cancer Pooling Project
- Published
- 2023
37. Data from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
- Author
-
Rayjean J. Hung, Brian E. Henderson, Christopher A. Haiman, David J. Hunter, Douglas F. Easton, Thomas A. Sellers, Christopher I. Amos, Stephen B. Gruber, Ulrike Peters, Jian Gong, Stephen J. Chanock, Daniela Seminara, Qiyuan Li, Matthew L. Freedman, Wim Timens, David Nickle, Ma'en Obeidat, Yohan Bossé, Atsushi Takahashi, Kouya Shiraishi, Xiao-Ou Shu, Zhibin Hu, Hongbing Shen, Yongyue Wei, David C. Christiani, Jonathan P. Tyrer, Y. Ann Chen, Patrick Sulem, Kari Stefansson, Simon N. Stacey, Julius Gudmundsson, Thorunn Rafnar, Michael O. Woods, Stephen N. Thibodeau, Stephanie L. Schmit, Noralene M. Lindor, Li Li, Loïc Le Marchand, Mark Jenkins, Robert W. Haile, Steven Gallinger, Christopher K. Edlund, David V. Conti, Graham Casey, Daniel D. Buchanan, Wei Zheng, Xiaohong R. Yang, Alice S. Whittemore, Zhaoming Wang, Andre G. Uitterlinden, Clare Turnbull, Ruth C. Travis, Rulla Tamimi, Melissa C. Southey, Rita K. Schmutzler, Daniel F. Schmidt, Maria Jose Sanchez, Nazneen Rahman, Ross L. Prentice, Julian Peto, Petra H. Peeters, Heli Nevanlinna, Taru A. Muranen, Bertram Müller-Myhsok, Alfons Meindl, Enes Makalic, Eiliv Lund, Jianjun Liu, Peter Lichtner, Muhammad G. Kibriya, Rudolf Kaaks, Mattias Johansson, Astrid Irwanto, John L. Hopper, Albert Hofman, Rebecca Hein, Aditi Hazra, Per Hall, Nichola Johnson, Mia M. Gaudet, Montserrat Garcia-Closas, Olivia Fletcher, Dieter Flesch-Janys, Jonine D. Figueroa, A. Heather Eliassen, Isabel dos-Santos-Silva, Kamila Czene, Federico Canzian, Carl Blomquist, Laura Baglietto, Kristiina Aittomäki, Habibul Ahsan, Muriel A. Adank, Emily White, Martha L. Slattery, Robert E. Schoen, Polly A. Newcomb, Jonathan K. Kocarnik, Thomas J. Hudson, Jenny Chang-Claude, Andrew T. Chan, Hermann Brenner, Stephane Bezieau, Brett M. Reid, Harvey A. Risch, Jennifer B. Permuth, Ellen L. Goode, Walter C. Willett, Fredrik Wiklund, Victoria L. Stevens, Meir J. Stampfer, Kenneth Muir, Jing Ma, Zsofia Kote-Jarai, Henrik Grönberg, Edward L. Giovannucci, Sonja I. Berndt, Ali Amin Al Olama, Angela Risch, Neil Caporaso, Maria Teresa Landi, Richard S. Houlston, Heike Bickeböller, Paul Brennan, Sara Lindström, Joellen M. Schildkraut, Fredrick R. Schumacher, Nilanjan Chatterjee, Rosalind A. Eeles, Paul D. Pharoah, Peter Kraft, and Gordon Fehringer
- Abstract
Identifying genetic variants with pleiotropic associations can uncover common pathways influencing multiple cancers. We took a two-stage approach to conduct genome-wide association studies for lung, ovary, breast, prostate, and colorectal cancer from the GAME-ON/GECCO Network (61,851 cases, 61,820 controls) to identify pleiotropic loci. Findings were replicated in independent association studies (55,789 cases, 330,490 controls). We identified a novel pleiotropic association at 1q22 involving breast and lung squamous cell carcinoma, with eQTL analysis showing an association with ADAM15/THBS3 gene expression in lung. We also identified a known breast cancer locus CASP8/ALS2CR12 associated with prostate cancer, a known cancer locus at CDKN2B-AS1 with different variants associated with lung adenocarcinoma and prostate cancer, and confirmed the associations of a breast BRCA2 locus with lung and serous ovarian cancer. This is the largest study to date examining pleiotropy across multiple cancer-associated loci, identifying common mechanisms of cancer development and progression. Cancer Res; 76(17); 5103–14. ©2016 AACR.
- Published
- 2023
38. Supplementary Table 1 from Alcohol Consumption in Relation to Plasma Sex Hormones, Prolactin, and Sex Hormone–Binding Globulin in Premenopausal Women
- Author
-
A. Heather Eliassen, Susan E. Hankinson, Walter C. Willett, Donna Spiegelman, and Kelly A. Hirko
- Abstract
Spearman rank correlation coefficients for sex hormone concentrations among 2,000 premenopausal women in the Nurses’ Health Study II.
- Published
- 2023
39. Supplementary Table 1 from Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
- Author
-
Peter Kraft, Regina G. Ziegler, Elio Riboli, Rudolf Kaaks, Shumin M. Zhang, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Rosario Tumino, Dimitrios Trichopoulos, Anne Tjønneland, Michael J. Thun, Gilles Thomas, Daniel O. Stram, Pär Stattin, Meir J. Stampfer, Maria-José Sánchez, Carlotta Sacerdote, Laudina Rodriguez, Kim Overvad, N. Charlotte Onland-Moret, Jing Ma, Eiliv Lund, Loic LeMarchand, I-Min Lee, Pagona Lagiou, Laurence N. Kolonel, Kay-Tee Khaw, Timothy J. Key, Mattias Johansson, Robert N. Hoover, David J. Hunter, Brian E. Henderson, Richard B. Hayes, Susan E. Hankinson, Christopher A. Haiman, Edward L. Giovannucci, J. Michael Gaziano, Vanessa Dumeaux, Françoise Clavel-Chapelon, Stephen J. Chanock, Nathalie Chabbert-Buffet, Julie E. Buring, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Christine D. Berg, Demetrius Albanes, Naomi E. Allen, Federico Canzian, Fredrick R. Schumacher, and Fangyi Gu
- Abstract
Supplementary Table 1 from Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
- Published
- 2023
40. Table S1 from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium
- Author
-
Anthony J. Swerdlow, Dale P. Sandler, Wei Zheng, Anne Zeleniuch-Jacquotte, Alicja Wolk, Walter C. Willett, Elisabete Weiderpass, Kala Visvanathan, Lars Vatten, Antonia Trichopoulou, Rulla M. Tamimi, Malin Sund, Atsuko Sadakane, Thomas E. Rohan, Elio Riboli, Petra H. Peeters, Julie R. Palmer, Kotaro Ozasa, Kim Overvad, Carmen Navarro, Roger L. Milne, Melissa A. Merritt, Huiyan Ma, Eiliv Lund, Susanna C. Larsson, Woon-Puay Koh, Cari M. Kitahara, Victoria A. Kirsh, Timothy J. Key, Rudolf Kaaks, Judy Hoffman-Bolton, Susan E. Hankinson, Inger T. Gram, Graham G. Giles, A. Heather Eliassen, Laure Dossus, Michele M. Doody, Yu Chen, Lesley Butler, Marie-Christine Boutron-Ruault, William J. Blot, Kimberly A. Bertrand, Leslie Bernstein, Laura Baglietto, Claudia Agnoli, Hans-Olov Adami, Michael E. Jones, Kathleen M. McClain, Mark N. Brook, Craig McGowan, Lauren B. Wright, Minouk J. Schoemaker, and Hazel B. Nichols
- Abstract
Supplementary table 1: Overview of the number of cohort studies providing information on each type of risk factor in the pooled data set
- Published
- 2023
41. Data from Dietary Patterns and Plasma Sex Hormones, Prolactin, and Sex Hormone–Binding Globulin in Premenopausal Women
- Author
-
A. Heather Eliassen, Susan E. Hankinson, Walter C. Willett, Eunyoung Cho, Junaidah B. Barnett, Donna Spiegelman, and Kelly A. Hirko
- Abstract
Background: Sex hormones are important for breast cancer, but it is unclear whether dietary patterns influence hormone concentrations.Methods: Dietary pattern adherence scores for the alternate Mediterranean diet (aMED), Dietary Approaches to Stop Hypertension (DASH), and Alternative Healthy Eating Index (AHEI) were calculated from semiquantitative food frequency questionnaires administered in 1995 and 1999. Premenopausal plasma concentrations of sex hormones were measured in samples collected in 1996 to 1999. We used generalized linear models to calculate geometric mean hormone concentrations across quartiles of dietary pattern scores among 1,990 women in the Nurses' Health Study II.Results: We did not observe significant associations between sex hormone concentrations and the DASH pattern and only one suggestive association between follicular estrone concentrations and the aMED pattern [top vs. bottom quartile −4.4%, 95% confidence interval (CI), −10.6% to 2.1%; Ptrend = 0.06]. However, women in the top versus bottom quartile of AHEI score had lower concentrations of follicular (−9.1%; 95% CI, −16.1% to −1.4%; Ptrend = 0.04) and luteal (−7.5%; 95% CI, −13.6% to −0.9%; Ptrend = 0.01) estrone, luteal-free (−9.3%; 95% CI, −16.8% to −1.1%; Ptrend = 0.01) and total (−6.7 %; 95% CI, −14.3% to 1.5%; Ptrend = 0.04) estradiol, follicular estradiol (−14.2%; 95% CI, −24.6% to −2.4%; Ptrend = 0.05), and androstenedione (−7.8%; 95% CI, −15.4% to 0.4%; Ptrend = 0.03).Conclusion: Diet quality measured by the AHEI is inversely associated with premenopausal estrogen concentrations. Given that we did not observe similar associations with the aMED or DASH patterns, our findings should be interpreted with caution.Impact: Given the role of estrogens in breast cancer etiology, our findings add to the substantial evidence on the benefits of adhering to a healthy diet. Cancer Epidemiol Biomarkers Prev; 25(5); 791–8. ©2016 AACR.
- Published
- 2023
42. Suupplementary Tables S1-S7 from Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer
- Author
-
Walter C. Willett, Wendy Y. Chen, Eunyoung Cho, A. Heather Eliassen, and Maryam S. Farvid
- Abstract
Table S1: Definitions for early adulthood various dairy products subgroups.Table S2: Definitions for adolescent various dairy products subgroups. Table S3: Age-standardized characteristics in 1998 according to intake of total dairy products during adolescence among women enrolled in the Nurses’ Health Study II. Table S4. Hazard ratios (HR) and 95% confidence intervals (95% CI) for breast cancer according to adolescent dairy product items.Table S5. Hazard ratios (HR) and 95% confidence intervals (95% CI) for breast cancer according to quintile of early adulthood dairy products items. Table S6. Hazard ratios (HR) and 95% confidence intervals (95%CI) for breast cancer according to quintile of adolescent calcium, vitamin D, and lactose intake. Table S7. Hazard ratios (HR) and 95% confidence intervals (95% CI) for breast cancer according to quintile of early adulthood calcium, vitamin D, and lactose intake.
- Published
- 2023
43. Supplemental Table 1 from Dietary Patterns and Plasma Sex Hormones, Prolactin, and Sex Hormone–Binding Globulin in Premenopausal Women
- Author
-
A. Heather Eliassen, Susan E. Hankinson, Walter C. Willett, Eunyoung Cho, Junaidah B. Barnett, Donna Spiegelman, and Kelly A. Hirko
- Abstract
Supplemental Table 1. P-value for trend of associations of AHEI (not including alcohol) dietary pattern score omitting individual food components and estrogen concentrations among up to 1,990 premenopausal women in the Nurses' Health Study II.
- Published
- 2023
44. Data from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium
- Author
-
Anthony J. Swerdlow, Dale P. Sandler, Wei Zheng, Anne Zeleniuch-Jacquotte, Alicja Wolk, Walter C. Willett, Elisabete Weiderpass, Kala Visvanathan, Lars Vatten, Antonia Trichopoulou, Rulla M. Tamimi, Malin Sund, Atsuko Sadakane, Thomas E. Rohan, Elio Riboli, Petra H. Peeters, Julie R. Palmer, Kotaro Ozasa, Kim Overvad, Carmen Navarro, Roger L. Milne, Melissa A. Merritt, Huiyan Ma, Eiliv Lund, Susanna C. Larsson, Woon-Puay Koh, Cari M. Kitahara, Victoria A. Kirsh, Timothy J. Key, Rudolf Kaaks, Judy Hoffman-Bolton, Susan E. Hankinson, Inger T. Gram, Graham G. Giles, A. Heather Eliassen, Laure Dossus, Michele M. Doody, Yu Chen, Lesley Butler, Marie-Christine Boutron-Ruault, William J. Blot, Kimberly A. Bertrand, Leslie Bernstein, Laura Baglietto, Claudia Agnoli, Hans-Olov Adami, Michael E. Jones, Kathleen M. McClain, Mark N. Brook, Craig McGowan, Lauren B. Wright, Minouk J. Schoemaker, and Hazel B. Nichols
- Abstract
Breast cancer is a leading cancer diagnosis among premenopausal women around the world. Unlike rates in postmenopausal women, incidence rates of advanced breast cancer have increased in recent decades for premenopausal women. Progress in identifying contributors to breast cancer risk among premenopausal women has been constrained by the limited numbers of premenopausal breast cancer cases in individual studies and resulting low statistical power to subcategorize exposures or to study specific subtypes. The Premenopausal Breast Cancer Collaborative Group was established to facilitate cohort-based analyses of risk factors for premenopausal breast cancer by pooling individual-level data from studies participating in the United States National Cancer Institute Cohort Consortium. This article describes the Group, including the rationale for its initial aims related to pregnancy, obesity, and physical activity. We also describe the 20 cohort studies with data submitted to the Group by June 2016. The infrastructure developed for this work can be leveraged to support additional investigations. Cancer Epidemiol Biomarkers Prev; 26(9); 1360–9. ©2017 AACR.
- Published
- 2023
45. Supplementary Table 1 from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
- Author
-
Rayjean J. Hung, Brian E. Henderson, Christopher A. Haiman, David J. Hunter, Douglas F. Easton, Thomas A. Sellers, Christopher I. Amos, Stephen B. Gruber, Ulrike Peters, Jian Gong, Stephen J. Chanock, Daniela Seminara, Qiyuan Li, Matthew L. Freedman, Wim Timens, David Nickle, Ma'en Obeidat, Yohan Bossé, Atsushi Takahashi, Kouya Shiraishi, Xiao-Ou Shu, Zhibin Hu, Hongbing Shen, Yongyue Wei, David C. Christiani, Jonathan P. Tyrer, Y. Ann Chen, Patrick Sulem, Kari Stefansson, Simon N. Stacey, Julius Gudmundsson, Thorunn Rafnar, Michael O. Woods, Stephen N. Thibodeau, Stephanie L. Schmit, Noralene M. Lindor, Li Li, Loïc Le Marchand, Mark Jenkins, Robert W. Haile, Steven Gallinger, Christopher K. Edlund, David V. Conti, Graham Casey, Daniel D. Buchanan, Wei Zheng, Xiaohong R. Yang, Alice S. Whittemore, Zhaoming Wang, Andre G. Uitterlinden, Clare Turnbull, Ruth C. Travis, Rulla Tamimi, Melissa C. Southey, Rita K. Schmutzler, Daniel F. Schmidt, Maria Jose Sanchez, Nazneen Rahman, Ross L. Prentice, Julian Peto, Petra H. Peeters, Heli Nevanlinna, Taru A. Muranen, Bertram Müller-Myhsok, Alfons Meindl, Enes Makalic, Eiliv Lund, Jianjun Liu, Peter Lichtner, Muhammad G. Kibriya, Rudolf Kaaks, Mattias Johansson, Astrid Irwanto, John L. Hopper, Albert Hofman, Rebecca Hein, Aditi Hazra, Per Hall, Nichola Johnson, Mia M. Gaudet, Montserrat Garcia-Closas, Olivia Fletcher, Dieter Flesch-Janys, Jonine D. Figueroa, A. Heather Eliassen, Isabel dos-Santos-Silva, Kamila Czene, Federico Canzian, Carl Blomquist, Laura Baglietto, Kristiina Aittomäki, Habibul Ahsan, Muriel A. Adank, Emily White, Martha L. Slattery, Robert E. Schoen, Polly A. Newcomb, Jonathan K. Kocarnik, Thomas J. Hudson, Jenny Chang-Claude, Andrew T. Chan, Hermann Brenner, Stephane Bezieau, Brett M. Reid, Harvey A. Risch, Jennifer B. Permuth, Ellen L. Goode, Walter C. Willett, Fredrik Wiklund, Victoria L. Stevens, Meir J. Stampfer, Kenneth Muir, Jing Ma, Zsofia Kote-Jarai, Henrik Grönberg, Edward L. Giovannucci, Sonja I. Berndt, Ali Amin Al Olama, Angela Risch, Neil Caporaso, Maria Teresa Landi, Richard S. Houlston, Heike Bickeböller, Paul Brennan, Sara Lindström, Joellen M. Schildkraut, Fredrick R. Schumacher, Nilanjan Chatterjee, Rosalind A. Eeles, Paul D. Pharoah, Peter Kraft, and Gordon Fehringer
- Abstract
Variants selected for replication
- Published
- 2023
46. Supplementary Material: Funding, Acknowledgements, Consortia, and Bioinformatics Tools Funding sources from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
- Author
-
Rayjean J. Hung, Brian E. Henderson, Christopher A. Haiman, David J. Hunter, Douglas F. Easton, Thomas A. Sellers, Christopher I. Amos, Stephen B. Gruber, Ulrike Peters, Jian Gong, Stephen J. Chanock, Daniela Seminara, Qiyuan Li, Matthew L. Freedman, Wim Timens, David Nickle, Ma'en Obeidat, Yohan Bossé, Atsushi Takahashi, Kouya Shiraishi, Xiao-Ou Shu, Zhibin Hu, Hongbing Shen, Yongyue Wei, David C. Christiani, Jonathan P. Tyrer, Y. Ann Chen, Patrick Sulem, Kari Stefansson, Simon N. Stacey, Julius Gudmundsson, Thorunn Rafnar, Michael O. Woods, Stephen N. Thibodeau, Stephanie L. Schmit, Noralene M. Lindor, Li Li, Loïc Le Marchand, Mark Jenkins, Robert W. Haile, Steven Gallinger, Christopher K. Edlund, David V. Conti, Graham Casey, Daniel D. Buchanan, Wei Zheng, Xiaohong R. Yang, Alice S. Whittemore, Zhaoming Wang, Andre G. Uitterlinden, Clare Turnbull, Ruth C. Travis, Rulla Tamimi, Melissa C. Southey, Rita K. Schmutzler, Daniel F. Schmidt, Maria Jose Sanchez, Nazneen Rahman, Ross L. Prentice, Julian Peto, Petra H. Peeters, Heli Nevanlinna, Taru A. Muranen, Bertram Müller-Myhsok, Alfons Meindl, Enes Makalic, Eiliv Lund, Jianjun Liu, Peter Lichtner, Muhammad G. Kibriya, Rudolf Kaaks, Mattias Johansson, Astrid Irwanto, John L. Hopper, Albert Hofman, Rebecca Hein, Aditi Hazra, Per Hall, Nichola Johnson, Mia M. Gaudet, Montserrat Garcia-Closas, Olivia Fletcher, Dieter Flesch-Janys, Jonine D. Figueroa, A. Heather Eliassen, Isabel dos-Santos-Silva, Kamila Czene, Federico Canzian, Carl Blomquist, Laura Baglietto, Kristiina Aittomäki, Habibul Ahsan, Muriel A. Adank, Emily White, Martha L. Slattery, Robert E. Schoen, Polly A. Newcomb, Jonathan K. Kocarnik, Thomas J. Hudson, Jenny Chang-Claude, Andrew T. Chan, Hermann Brenner, Stephane Bezieau, Brett M. Reid, Harvey A. Risch, Jennifer B. Permuth, Ellen L. Goode, Walter C. Willett, Fredrik Wiklund, Victoria L. Stevens, Meir J. Stampfer, Kenneth Muir, Jing Ma, Zsofia Kote-Jarai, Henrik Grönberg, Edward L. Giovannucci, Sonja I. Berndt, Ali Amin Al Olama, Angela Risch, Neil Caporaso, Maria Teresa Landi, Richard S. Houlston, Heike Bickeböller, Paul Brennan, Sara Lindström, Joellen M. Schildkraut, Fredrick R. Schumacher, Nilanjan Chatterjee, Rosalind A. Eeles, Paul D. Pharoah, Peter Kraft, and Gordon Fehringer
- Abstract
Funding sources, acknowledgements, consortia involved in study and bioinformatics tools used
- Published
- 2023
47. Supplementary Tables 1-2 from Urinary Estrogens and Estrogen Metabolites and Subsequent Risk of Breast Cancer among Premenopausal Women
- Author
-
Regina G. Ziegler, Susan E. Hankinson, Walter C. Willett, Robert L. Barbieri, Timothy D. Veenstra, Larry K. Keefer, Xia Xu, Donna Spiegelman, and A. Heather Eliassen
- Abstract
PDF file - 79K
- Published
- 2023
48. Intakes of Unprocessed and Minimally Processed and Ultraprocessed Food Are Associated with Diet Quality in Female and Male Health Professionals in the United States: A Prospective Analysis
- Author
-
Sinara Laurini Rossato, Neha Khandpur, Chun-Han Lo, Stela Maris Jezus Castro, Jean Philippe Drouin-Chartier, Laura Sampson, Changzheng Yuan, Cristiane Murta-Nascimento, Maria Antonieta Carvalhaes, Carlos Augusto Monteiro, Qi Sun, Teresa T. Fung, and Walter C. Willett
- Subjects
Nutrition and Dietetics ,General Medicine ,Food Science - Published
- 2023
49. Ultra-processed food consumption and risk of type 2 diabetes: three large prospective U.S. cohort studies
- Author
-
Zhangling Chen, Neha Khandpur, Clémence Desjardins, Lu Wang, Carlos A. Monteiro, Sinara L. Rossato, Teresa T. Fung, JoAnn E. Manson, Walter C. Willett, Eric B. Rimm, Frank B. Hu, Qi Sun, and Jean-Philippe Drouin-Chartier
- Subjects
Advanced and Specialized Nursing ,Endocrinology, Diabetes and Metabolism ,Internal Medicine - Abstract
OBJECTIVE We examined the relationship between ultra-processed food (UPF) intake and type 2 diabetes (T2D) risk among 3 large U.S. cohorts, conducted a meta-analysis of prospective cohort studies, and assessed meta-evidence quality. RESEARCH DESIGN AND METHODS We included 71,871 women from the Nurses’ Health Study, 87,918 women from the Nurses’ Health Study II, and 38,847 men from the Health Professional Follow-Up Study. Diet was assessed using food frequency questionnaires and UPF was categorized per the NOVA classification. Associations of total and subgroups of UPF with T2D were assessed using Cox proportional hazards models. We subsequently conducted a meta-analysis of prospective cohort studies on total UPF and T2D risk, and assessed meta-evidence quality using the NutriGrade scoring system. RESULTS Among the U.S. cohorts (5,187,678 person-years; n = 19,503 T2D cases), the hazard ratio for T2D comparing extreme quintiles of total UPF intake (percentage of grams per day) was 1.46 (95% CI 1.39–1.54). Among subgroups, refined breads; sauces, spreads, and condiments; artificially and sugar-sweetened beverages; animal-based products; and ready-to-eat mixed dishes were associated with higher T2D risk. Cereals; dark and whole-grain breads; packaged sweet and savory snacks; fruit-based products; and yogurt and dairy-based desserts were associated with lower T2D risk. In the meta-analysis (n = 415,554 participants; n = 21,932 T2D cases), each 10% increment in total UPF was associated with a 12% (95% CI 10%–13%) higher risk. Per NutriGrade, high-quality evidence supports this relationship. CONCLUSION High-quality meta-evidence shows that total UPF consumption is associated with higher T2D risk. However, some UPF subgroups were associated with lower risk in the U.S. cohorts.
- Published
- 2023
50. Abstract P216: Carbohydrate Quantity and Quality, and Risk of Type 2 Diabetes: Results From Three Large Prospective US Cohorts
- Author
-
Caleigh M Sawicki, Kim V Braun, Danielle E Haslam, Hala B Alessa, Walter C Willett, Frank B Hu, and Shilpa N Bhupathiraju
- Subjects
Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Background: High-quality carbohydrate sources, such as whole grains, have been associated with a lower risk of type 2 diabetes (T2D), whereas low-quality carbohydrate sources, such as refined grains and added sugar, have been associated with a higher T2D risk. However, few studies have considered how replacing dietary carbohydrate with other macronutrients may influence T2D risk. Objective: We examined whether isocaloric substitution of high- or low-quality carbohydrate for fat, protein, and their subtypes is associated with T2D risk. Methods: We included 75,430 women from the Nurses' Health Study (1984-2016), 85,630 women from the Nurses' Health Study II (1991-2017), and 40,261 men from the Health Professionals Follow-Up Study (1986-2016) who were free of T2D, CVD, and cancer at baseline. Dietary data were collected every 2-4 years using a validated, semi-quantitative food frequency questionnaire. High-quality carbohydrate was defined as carbohydrate from whole grains, fruits, vegetables, and legumes. Low-quality carbohydrate was defined as carbohydrate from refined grains, added sugars, and potatoes. We used Cox proportional hazards regression with time-varying covariates to model the substitution of 5% of energy intake from high- and low-quality carbohydrate for isocaloric amounts of fat, protein, and their subtypes [polyunsaturated fat (PUFA), animal and plant monounsaturated fat (MUFA), saturated fat, trans fat, and animal and plant protein]. Cohort-specific estimates were combined using inverse variance-weighted fixed effects meta-analyses. Results: During 4,859,845 years of follow-up, we documented 20,141 incident T2D cases. In multivariable-adjusted meta-analyses, isocaloric substitution of high-quality carbohydrate for total fat [HR (95% CI) 0.94 (0.93, 0.96)], total MUFA [0.95 (0.91, 0.98)], MUFA from animal sources [0.92 (0.88, 0.95)], total protein [0.91 (0.89, 0.94)], or animal protein [0.94 (0.91, 0.97] was associated with a lower T2D risk. On the other hand, the substitution of low-quality carbohydrate for plant MUFA [1.06 (1.02-1.10)] or plant protein [1.06 (1.02-1.11)] was associated with a higher risk of T2D. When we restricted high-quality carbohydrate sources to whole grains, the results were similar or stronger. Additionally, substitution of whole grain carbohydrate for saturated fat [0.87 (0.84, 0.91)], trans fat [0.87 (0.83, 0.92)], PUFA [0.88 (0.84, 0.92)], plant MUFA [0.92 (0.87, 0.96)], or plant protein [0.91 (0.86, 0.97)] was associated with lower T2D risk. Conclusions: The effect of carbohydrate substitution on T2D risk depends not only on the nutrient being substituted but also on the quality of the carbohydrate. Substitution of high-quality carbohydrate, especially carbohydrate from whole grains (i.e. whole wheat bread, oatmeal), for fat or protein, especially animal sources (i.e. beef, poultry), may lower T2D risk.
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.